drugset / Trial / NCT02353273

The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers

NCT02353273 ↗

Phase 1 Completed 12 enrolled Oneness Biotech Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the systemic exposures of WH-1 ointment which includes Salvigenin and Asiaticoside A in subjects with chronic diabetic foot ulcers following topical application of WH-1.

Timeline

Start
2015-07-22
Primary completion
2016-07-05
Completion
2016-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject WH-1 ointment Unknown 1.25 % Topical

Indications

No indication recorded.